The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

The future landscape of cancer incidence and mortality until 2036 in the Russian Federation.

Ilya  Tsimafeyeu

Leadership - Ruspharmtech

Stock and Other Ownership Interests  - Ruspharmtech

Honoraria - Bristol-Myers Squibb/Celgene; Novartis; Pfizer

Consulting or Advisory Role - Novartis; Pfizer

Speakers' Bureau - AstraZeneca; Novartis; Pfizer; Ruspharmtech

Research Funding - Novartis (Inst); Pfizer (Inst)

Patents, Royalties, Other Intellectual Property - Kidney Cancer Research Bureau; Oncomax LLC; Ruspharmtech

Lola  Rahib

No Relationships to Disclose